Screener
Relmada Therapeutics, Inc. RLMD Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
| Line item | As of / March 31, | As of |
|---|---|---|
| Prepaid expenses | 1,380,151 | 977,721 |
| Total current assets | 235,343,294 | 93,983,971 |
| Other assets | 19,500 | 19,500 |
| Total assets | $235,362,794 | $94,003,471 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $5,731,401 | $1,568,944 |
| Accrued expenses | 7,160,233 | 4,861,583 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Relmada Therapeutics, Inc.'s total assets?
- Relmada Therapeutics, Inc. (RLMD) reported total assets of $235.36M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s total assets changed year-over-year?
- Relmada Therapeutics, Inc.'s total assets increased by 750.3% year-over-year, from $27.68M to $235.36M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s total assets has grown at a -4.5% compound annual growth rate (CAGR), from $118.19M to $94M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Relmada Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude